Literature DB >> 15675555

Analysis of Mycobacterium tuberculosis isolates from treatment failure patients living in East Timor.

P M Kelly1, R Lumb, A Pinto, G da Costa, J Sarmento, I Bastian.   

Abstract

SETTING: In the first 2 years of the East Timor National TB Control Programme, 7960 new patients were treated (2RHZE/6HE) and 224 received a retreatment regimen (2SRHZE/1RHZE/4R3H3Z3E3).
OBJECTIVE: To determine the nature and extent of drug-resistant tuberculosis (TB) in treatment failure cases in East Timor.
METHODS: Sputum specimens from retreatment failure cases were processed and inoculated into a BACTEC MGIT960 tube and onto Löwenstein-Jensen media. Isolates were identified by Ziehl-Neelsen staining, hybridisation with nucleic acid probes and biochemical investigations. Susceptibility testing was performed using the radiometric proportion method. Pyrazinamide testing was performed using the Wayne indirect method.
RESULTS: Eighteen patients failed retreatment (0.7% of new cases) and 14 were available for analysis. Mycobacterium tuberculosis was cultured from all specimens, despite considerable transport delays. Nine (64.3%) had multiple drug resistance (MDR-TB) and four (28.6%) had other drug resistance. All MDR-TB isolates were susceptible to amikacin, capreomycin and ethionamide, with most also susceptible to ciprofloxacin and para-aminosalicylic acid (PAS).
CONCLUSIONS: An excellent TB control programme has been established in East Timor. If funds are available, East Timor provides an ideal setting for a small-scale DOTS-Plus programme to treat prevalent cases of MDR-TB, and this study could inform the second-line drug regimen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15675555

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  7 in total

1.  An alternative method for sputum storage and transport for mycobacterium tuberculosis drug resistance surveys.

Authors:  R Lumb; M Ardian; G Waramori; H Syahrial; E Tjitra; G P Maguire; N M Anstey; P M Kelly
Journal:  Int J Tuberc Lung Dis       Date:  2006-02       Impact factor: 2.373

2.  The case of the Democratic Republic of Timor-Leste.

Authors:  Einar Heldal; Rui Maria de Araujo; Nelson Martins; Jaime Sarmento; Constantino Lopez
Journal:  Bull World Health Organ       Date:  2007-08       Impact factor: 9.408

Review 3.  Epidemiology and treatment of multidrug resistant tuberculosis.

Authors:  Carole D Mitnick; Sasha C Appleton; Sonya S Shin
Journal:  Semin Respir Crit Care Med       Date:  2008-09-22       Impact factor: 3.119

4.  Map the gap: missing children with drug-resistant tuberculosis.

Authors:  C M Yuen; C A Rodriguez; S Keshavjee; M C Becerra
Journal:  Public Health Action       Date:  2015-03-21

5.  Transmission pattern of drug-resistant tuberculosis and its implication for tuberculosis control in eastern rural China.

Authors:  Yi Hu; Barun Mathema; Weili Jiang; Barry Kreiswirth; Weibing Wang; Biao Xu
Journal:  PLoS One       Date:  2011-05-12       Impact factor: 3.240

6.  Mechanisms of first-line antimicrobial resistance in multi-drug and extensively drug resistant strains of Mycobacterium tuberculosis in KwaZulu-Natal, South Africa.

Authors:  Navisha Dookie; A Willem Sturm; Prashini Moodley
Journal:  BMC Infect Dis       Date:  2016-10-26       Impact factor: 3.090

Review 7.  A Global Perspective on Pyrazinamide Resistance: Systematic Review and Meta-Analysis.

Authors:  Michael G Whitfield; Heidi M Soeters; Robin M Warren; Talita York; Samantha L Sampson; Elizabeth M Streicher; Paul D van Helden; Annelies van Rie
Journal:  PLoS One       Date:  2015-07-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.